Staar Surgical Co has a consensus price target of $52.25, established from looking at the 53 latest analyst ratings. The last 3 analyst ratings were released from Mizuho, Canaccord Genuity, and Needham on April 11, 2024, April 8, 2024, and April 4, 2024. With an average price target of $33 between Mizuho, Canaccord Genuity, and Needham, there's an implied -29.47% downside for Staar Surgical Co from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
04/11/2024 | STAA | Buy Now | Staar Surgical | $46.79 | 13.27% | Mizuho | Anthony Petrone | $45 → $53 | Maintains | Buy | Get Alert |
04/08/2024 | STAA | Buy Now | Staar Surgical | $46.79 | -1.69% | Canaccord Genuity | Jon Young | $32 → $46 | Maintains | Hold | Get Alert |
04/04/2024 | STAA | Buy Now | Staar Surgical | $46.79 | — | Needham | David Saxon | — | Reiterates | → Hold | Get Alert |
04/01/2024 | STAA | Buy Now | Staar Surgical | $46.79 | 6.86% | Stifel | Thomas Stephan | $50 → $50 | Maintains | Buy | Get Alert |
03/11/2024 | STAA | Buy Now | Staar Surgical | $46.79 | 6.86% | Stifel | Thomas Stephan | $30 → $50 | Upgrade | Hold → Buy | Get Alert |
02/28/2024 | STAA | Buy Now | Staar Surgical | $46.79 | -3.83% | Mizuho | Anthony Petrone | $50 → $45 | Maintains | Buy | Get Alert |
02/27/2024 | STAA | Buy Now | Staar Surgical | $46.79 | -29.47% | Piper Sandler | Matt O'Brien | $40 → $33 | Maintains | Neutral | Get Alert |
12/05/2023 | STAA | Buy Now | Staar Surgical | $46.79 | — | Needham | David Saxon | — | Downgrade | Buy → Hold | Get Alert |
12/04/2023 | STAA | Buy Now | Staar Surgical | $46.79 | -25.2% | Morgan Stanley | Patrick Wood | → $35 | Initiates | → Equal-Weight | Get Alert |
11/02/2023 | STAA | Buy Now | Staar Surgical | $46.79 | -14.51% | Piper Sandler | Matt O'Brien | $45 → $40 | Maintains | Neutral | Get Alert |
11/02/2023 | STAA | Buy Now | Staar Surgical | $46.79 | 4.72% | Needham | David Saxon | $52 → $49 | Maintains | Buy | Get Alert |
09/22/2023 | STAA | Buy Now | Staar Surgical | $46.79 | -14.51% | Stifel | Thomas Stephan | $45 → $40 | Maintains | Hold | Get Alert |
09/15/2023 | STAA | Buy Now | Staar Surgical | $46.79 | -3.83% | Piper Sandler | Matt O'Brien | $50 → $45 | Maintains | Neutral | Get Alert |
09/15/2023 | STAA | Buy Now | Staar Surgical | $46.79 | 38.92% | Mizuho | Anthony Petrone | → $65 | Reiterates | Buy → Buy | Get Alert |
09/15/2023 | STAA | Buy Now | Staar Surgical | $46.79 | — | Benchmark | Bruce Jackson | — | Downgrade | Buy → Hold | Get Alert |
09/15/2023 | STAA | Buy Now | Staar Surgical | $46.79 | 11.13% | Needham | David Saxon | $54 → $52 | Maintains | Buy | Get Alert |
09/13/2023 | STAA | Buy Now | Staar Surgical | $46.79 | 38.92% | Mizuho | Anthony Petrone | → $65 | Reiterates | Buy → Buy | Get Alert |
09/13/2023 | STAA | Buy Now | Staar Surgical | $46.79 | -3.83% | Stifel | Thomas Stephan | → $45 | Reiterates | Hold → Hold | Get Alert |
08/21/2023 | STAA | Buy Now | Staar Surgical | $46.79 | -3.83% | Stifel | Thomas Stephan | $50 → $45 | Maintains | Hold | Get Alert |
The latest price target for Staar Surgical (NASDAQ: STAA) was reported by Mizuho on April 11, 2024. The analyst firm set a price target for $53.00 expecting STAA to rise to within 12 months (a possible 13.27% upside). 30 analyst firms have reported ratings in the last year.
The latest analyst rating for Staar Surgical (NASDAQ: STAA) was provided by Mizuho, and Staar Surgical maintained their buy rating.
The last upgrade for Staar Surgical Co happened on March 11, 2024 when Stifel raised their price target to $50. Stifel previously had a hold for Staar Surgical Co.
The last downgrade for Staar Surgical Co happened on December 5, 2023 when Needham changed their price target from N/A to N/A for Staar Surgical Co.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Staar Surgical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Staar Surgical was filed on April 11, 2024 so you should expect the next rating to be made available sometime around April 11, 2025.
While ratings are subjective and will change, the latest Staar Surgical (STAA) rating was a maintained with a price target of $45.00 to $53.00. The current price Staar Surgical (STAA) is trading at is $46.79, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.